The PROOF Centre partnership model drives biomarker development. Our business model allows us to bring in partners as early as possible to deliver much needed solutions to physicians and patients, while at the same time generating the necessary health care savings or return on investment for the government, academia, industry.
The PROOF Centre uses a Biomarker Development Pipeline to ensure success of Biomarker Programs underway in heart, lung and kidney failure as well as heart and kidney transplantation.
PROOF Centre Biomarker Development Pipeline
Our end-to-end approach from clinical need to clinical implementation.
PROOF Centre Biomarker Programs in the Development Pipeline
